Mexico slaps Lilly, Baxter with price-fixing fines

Six pharmaceutical companies--including Eli Lilly's Mexican unit and Baxter Healthcare--were fined more than 150 million pesos ($11.6 million) for conspiring to raise the price of medicines they sold to a social-services agency, Mexico's anti-monopoly commission said. Report